Medesis Pharma (France) Today
| ALMDP Stock | EUR 0.43 0.02 4.88% |
Performance0 of 100
| Odds Of DistressLess than 28
|
Medesis Pharma is selling at 0.43 as of the 22nd of November 2024; that is 4.88% up since the beginning of the trading day. The stock's last reported lowest price was 0.41. Medesis Pharma has about a 28 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Medesis Pharma SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of May 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Medesis Pharma SA, a clinical development stage biopharmaceutical company, engages in the development of orally administered molecule drug candidates to address unmet medical needs. The company was founded in 2003 and is based in Montpellier, France. MEDESIS PHARMA is traded on Paris Stock Exchange in France.. The company has 4.39 M outstanding shares. More on Medesis Pharma SA
Moving together with Medesis Stock
Moving against Medesis Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Medesis Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Medesis Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Medesis Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Medesis Pharma SA (ALMDP) is traded on Euronext Paris in France and employs 3 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.43 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medesis Pharma's market, we take the total number of its shares issued and multiply it by Medesis Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Medesis Pharma SA operates under Healthcare sector and is part of Biotechnology industry. The entity has 4.39 M outstanding shares.
Check Medesis Pharma Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Medesis Pharma SA is €13.43 Million. Medesis Pharma SA secures 17.28 % of its outstanding shares held by insiders and 0.0 % owned by institutional investors. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Medesis Ownership Details
Medesis Pharma SA Risk Profiles
Although Medesis Pharma's alpha and beta are two of the key measurements used to evaluate Medesis Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 6.67 | |||
| Standard Deviation | 10.91 | |||
| Variance | 119.06 | |||
| Risk Adjusted Performance | (0.01) |
Medesis Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medesis Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Additional Tools for Medesis Stock Analysis
When running Medesis Pharma's price analysis, check to measure Medesis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medesis Pharma is operating at the current time. Most of Medesis Pharma's value examination focuses on studying past and present price action to predict the probability of Medesis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medesis Pharma's price. Additionally, you may evaluate how the addition of Medesis Pharma to your portfolios can decrease your overall portfolio volatility.